Occlutech CEO Nabs Win In Patent Row With St. Jude Unit

Law360, New York (September 26, 2011, 7:12 PM EDT) -- Occlutech AB said Monday that a German court has struck down a patent infringement claim related to medical implants used to treat structural heart defects that was filed against the company's CEO by a unit of St. Jude Medical Inc.

In a statement, Occlutech said the district court in Dusseldorf, Germany, had issued a ruling on Sept. 8 rejecting a claim by St. Jude's AGA Medical Inc. that Occlutech CEO Tor Peters had violated a medical device patent related to intravascular occlusion devices. The ruling follows...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.